E. Bonetto

574 total citations
15 papers, 456 citations indexed

About

E. Bonetto is a scholar working on Oncology, Epidemiology and Radiation. According to data from OpenAlex, E. Bonetto has authored 15 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Epidemiology and 4 papers in Radiation. Recurrent topics in E. Bonetto's work include Pancreatic and Hepatic Oncology Research (8 papers), Colorectal Cancer Treatments and Studies (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). E. Bonetto is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Colorectal Cancer Treatments and Studies (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). E. Bonetto collaborates with scholars based in Italy and United Kingdom. E. Bonetto's co-authors include Valerio Di Carlo, Paolo Passoni, Michele Reni, Alessandro Zerbi, Roberto Nicoletti, C. Staudacher, Gianpaolo Balzano, Stefano Cordio, Carlo Milandri and Gabriele Luppi and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

E. Bonetto

13 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Bonetto Italy 9 396 176 158 148 72 15 456
Volker Lakner Germany 5 385 1.0× 157 0.9× 122 0.8× 115 0.8× 114 1.6× 7 451
James E. Krook United States 7 297 0.8× 110 0.6× 138 0.9× 92 0.6× 90 1.3× 9 427
Noël Stremsdoerfer France 5 517 1.3× 190 1.1× 311 2.0× 193 1.3× 166 2.3× 7 639
Edith Brutcher United States 12 373 0.9× 108 0.6× 130 0.8× 122 0.8× 158 2.2× 20 498
Robert S. Brody United States 6 269 0.7× 55 0.3× 176 1.1× 92 0.6× 55 0.8× 11 453
X. Tchiknavorian France 7 270 0.7× 98 0.6× 151 1.0× 41 0.3× 56 0.8× 13 362
Richard M. Goldberg United States 12 433 1.1× 214 1.2× 201 1.3× 114 0.8× 126 1.8× 33 644
Ren-bao Yang China 7 289 0.7× 122 0.7× 104 0.7× 68 0.5× 163 2.3× 9 451
N. Vardakis Greece 11 348 0.9× 113 0.6× 201 1.3× 37 0.3× 64 0.9× 35 436
Swee‐Peng Yap Singapore 7 287 0.7× 59 0.3× 255 1.6× 80 0.5× 59 0.8× 9 532

Countries citing papers authored by E. Bonetto

Since Specialization
Citations

This map shows the geographic impact of E. Bonetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bonetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bonetto more than expected).

Fields of papers citing papers by E. Bonetto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Bonetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bonetto. The network helps show where E. Bonetto may publish in the future.

Co-authorship network of co-authors of E. Bonetto

This figure shows the co-authorship network connecting the top 25 collaborators of E. Bonetto. A scholar is included among the top collaborators of E. Bonetto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Bonetto. E. Bonetto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Meregalli, Sofia, et al.. (2023). Updating approach for lexicographic optimization-based planning to improve cervical cancer plan quality. Discover Oncology. 14(1). 180–180.
3.
Meregalli, Sofia, et al.. (2022). Comprehensive dosimetric and clinical evaluation of lexicographic optimization-based planning for cervical cancer. Frontiers in Oncology. 12. 1041839–1041839. 6 indexed citations
4.
Monfardini, S., R. Valdagni, Mario Catanzaro, et al.. (2017). Follow-up of elderly patients with urogenital cancers: Evaluation of geriatric care needs and related actions. Journal of Geriatric Oncology. 8(4). 289–295. 7 indexed citations
5.
Maurizi, Francesca, Alberto Bonetta, Roberto Bortolus, et al.. (2011). 499 oral SALVAGE OR ADJUVANT? 5Y-RESULTS OF THE “AIRO NATIONAL WORKING GROUP ON PROSTATE RADIOTHERAPY” MULTICENTER PROSPECTIVE STUDY. Radiotherapy and Oncology. 99. S202–S202. 1 indexed citations
6.
Colombatti, Raffaella, Silverio Perrotta, Nicoletta Masera, et al.. (2010). Lessons learned from the H1N1 pandemic: The need to improve systematic vaccination in Sickle Cell Disease children. A multi center survey in Italy. Vaccine. 29(6). 1126–1128. 9 indexed citations
7.
Reni, Michele, Stefano Cereda, E. Bonetto, et al.. (2007). Dose-Intense PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) in Advanced Pancreatic Adenocarcinoma: A Dose-Finding Study. Cancer Investigation. 25(7). 594–598. 13 indexed citations
8.
Reni, Michele, Stefano Cereda, E. Bonetto, et al.. (2006). Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma. Cancer Chemotherapy and Pharmacology. 59(3). 361–367. 20 indexed citations
9.
Reni, Michele, Lara Maria Pasetto, Giuseppe Aprile, et al.. (2006). Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer. British Journal of Cancer. 94(6). 785–791. 62 indexed citations
10.
Reni, Michele, E. Bonetto, Stefano Cordio, et al.. (2006). Quality of life assessment in advanced pancreatic adenocarcinoma: Results from a phase III randomized trial. Pancreatology. 6(5). 454–463. 29 indexed citations
11.
Lissoni, Paolo, Sofia Meregalli, E. Bonetto, et al.. (2006). Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms.. PubMed. 19(3-4). 153–8. 42 indexed citations
13.
Reni, Michele, Stefano Cordio, Carlo Milandri, et al.. (2005). Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial. The Lancet Oncology. 6(6). 369–376. 222 indexed citations
14.
Reni, Michele, E. Bonetto, Lara Maria Pasetto, et al.. (2005). Raltitrexed-eloxatin (TOM OX) salvage chemotherapy (CHT) in gemcitabine (GEM) resistant metastatic pancreatic cancer (PC): a phase II trial. Journal of Clinical Oncology. 23(16_suppl). 4115–4115. 1 indexed citations
15.
Reni, Michele, Paolo Passoni, E. Bonetto, et al.. (2004). Salvage Chemotherapy with Mitomycin, Docetaxel, and Irinotecan (MDI Regimen) in Metastatic Pancreatic Adenocarcinoma: A Phase I and II Trial. Cancer Investigation. 22(5). 688–696. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026